Evidence map›Paper›PMID 34532071›Full record

ReviewEFORT open reviews2021

Giant cell tumour of bone around the knee: a systematic review of the functional and oncological outcomes.

Joaquim Soares do Brito, André Spranger, Paulo Almeida, José Portela, Irene Barrientos-Ruiz

Abstract readReview
In one paragraph

Review in EFORT open reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A New Relevant Integrated Radiologic and Surgical Classification Scheme for Giant Cell Tumors of Bones.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joaquim Soares do BritoOrthopedics Department, University Hospital of Santa Maria, Lisbon, Portugal.ORCID https://orcid.org/0000-0003-0132-7526
André SprangerOrthopedics Department, University Hospital of Santa Maria, Lisbon, Portugal.
Paulo AlmeidaOrthopedics Department, University Hospital of Santa Maria, Lisbon, Portugal.
José PortelaOrthopedics Department, University Hospital of Santa Maria, Lisbon, Portugal.
Irene Barrientos-RuizOrthopedics Department, University Hospital of La Paz, Madrid.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant cell tumour of bone (GCT) is a relatively rare, locally aggressive benign neoplasm observed in the long bone epiphyseal-metaphyseal regions of young adults.The optimal treatment strategy for these tumours remains controversial, and a huge amount of contradictory data regarding the functional and oncological outcomes can be found. Therefore, we performed a systematic review intended to investigate the functional and oncological outcomes after surgical treatment of GCTs arising around the knee, namely in the distal femur and proximal tibia.A trend towards better oncological control was found using wide resections, nonetheless, curettage-based techniques achieve a highly acceptable recurrence rate with overall better knee function. A slight advantage favouring proximal tibia GCTs regarding the Musculoskeletal Tumor Society (MSTS) score was also observed.Prospective studies comparing groups of more homogeneous patients, tumours, and treatment options should be developed to obtain more conclusive and definitive results regarding the optimal strategy for treating GCTs. Cite this article:

Indexed as

distal femur and proximal tibiagiant cell tumour of boneoncological and functional outcomes

Identifiers

PMID34532071
PMCPMC8419793

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.